Stay updated with breaking news from Behavioural Phenotypes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
14.11.2022 - Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel in patients with Fragile X syndrome (FXS); topline results expected second-half 2023 $55.9 million in cash and cash equivalents at September 30, 2022; Cash runway into ...
Let’s start up with the current stock price of Zynerba Pharmaceuticals Inc. (ZYNE), which is $1.12 to be very precise. The Stock rose vividly during the last session to $1.16 after opening rate of $1.15 while the lowest price it went was recorded $1.0813 before closing at $1.16.Recently in News on
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires